Compare studies and check their requirements with the research team.
This study is not recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.
In GermanyThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In ItalyThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In AustriaThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In ItalyThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In IrelandThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about Depression.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Depression.
This study is looking at whether Patients start with either phenelzine 15 mg or lithiumcarbonate 200 mg can help people with Depression, Mental and Behavioural Disorders, or 1. Depressive episode 2.
In NetherlandsThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including New HavenThis study is directly about Depression.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.